Bigul

Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

This is to inform you that the Nomination & Remuneration Committee of Board of Directors of the Company has allotted on December 17, 2022 by way of resolution passed by circulation 11,44,135 Equity Shares of Rs.2/- each of the Company, fully paid up, at a price of Rs. 58.40/- each (including premium of Rs. 56.40/-), to the eligible Employees on exercise of their Stock Options under Laurus Employees Stock Option Scheme, 2016. Further, the Nomination & Remuneration Committee of Board of Directors of the Company has allotted on December 17, 2022 by way of resolution passed by circulation 1,47,455 Equity Shares of Rs.2/- each of the Company, fully paid up, at a price of Rs. 51.10/- each (including premium of Rs. 49.10/-), to the eligible Employees on exercise of their Stock Options under Laurus Employees Stock Option Scheme, 2018. The total paid up capital of the Company after the above allotments stands at Rs.107,73,01,850/-.
17-12-2022
Bigul

Laurus Labs Ltd - 540222 - Reply To Clarification Sought By The Exchange

With reference to your email dated November 30, 2022 vide reference no. L/SURV/ONL/PV/KB/ 2022-2023/305 seeking clarification on increase in Volume of the Securities of the Company on the Exchanges, we hereby inform you that the Company has been disclosing all the events, information etc. that have a bearing on the operation/performance of the company, which include all price sensitive information, etc. as per the requirements under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI (LODR), Regulations, 2015'), from time to time. We further inform you that the Company do not have any information/announcement to be disclosed with the Stock Exchanges as per the requirements under Regulation 30 of the SEBI (LODR), Regulations, 2015, and we shall disclose any material information/announcement as and when it is required to be informed as per SEBI (LODR) Regulations.
30-11-2022
Bigul

Laurus Labs Ltd - 540222 - Clarification sought from Laurus Labs Ltd

The Exchange has sought clarification from Laurus Labs Ltd on November 30, 2022, with reference to Movement in Volume.The reply is awaited.
30-11-2022

Laurus Labs slumps to 52-week low as Kotak Institutional Equities downgrades stock

Kotak has downgraded Laurus Labs to sell with a fair value of Rs 350/share, dragging the stock to intraday low of Rs 417
29-11-2022
Bigul

Laurus Labs Ltd - 540222 - Entering Into Share Subscription Agreement And Shareholders' Agreement With M/S. Ethan Energy India Private Limited

This is to inform you that Laurus Labs Limited ('the Company'), as per the policy of the Government for captive consumption of power, has entered into Share Subscription Agreement and Shareholders' Agreement on November 23, 2022 with M/s.Ethan Energy India Private Limited for subscribing 7,40,000 (Seven Lakh Forty Thousand) Equity Shares of face value of INR 10/-(Indian Rupees Ten Only) each at a premium of INR 42.70 /- (Indian Rupees Forty Two Seventy Paise Only) which is equivalent to 26% of the paid up capital of Ethan Energy India Private Limited. This will enable the Company to consume 100% of the solar energy to be supplied by Ethan Energy India Private Limited from their 10 MW Solar Energy plant.
24-11-2022
Bigul

Laurus Labs Ltd - 540222 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015

Please find enclosed herewith a letter received from M/s. Leven Holdings (a Partnership Firm, where Mr. V.V Ravi Kumar, Promoter, Executive Director and CFO of Laurus Labs Limited ('the Company'), as a Managing Trustee of M/s. VVRK Family Trust is the Managing Partner) stating that Mr. V.V.Ravi Kumar had transferred 67,05,000 equity shares of the Company held by him to M/s. Leven Holdings as capital contribution to the said Partnership Firm. These 67,05,000 equity shares of Rs.2/- each represents 1.25% of shareholding of the Company. Post-transfer of above shares to M/s. Leven Holdings on 2nd November 2022, Mr. V.V Ravi Kumar still holds 10,00,000 equity shares of Rs.2/- each of the Company in his individual capacity representing 0.18% of shareholding in the Company. Accordingly, M/s. Leven Holdings has been categorised under the Promoter Category of the Company with immediate effect.
03-11-2022
Bigul

Laurus Labs Ltd - 540222 - Related Party Transactions For September 30, 2022

Related Party Transactions for September 30, 2022
02-11-2022
Bigul

Laurus Labs Ltd - 540222 - USFDA Pre-Approval Inspection (PAI) At Our Manufacturing Facility At Unit-5

This is to inform you that US Food and Drug Administration (USFDA) today completed a Pre-Approval Inspection (PAI) at our manufacturing facility at Unit-5, Parawada, Visakhapatnam, Andhra Pradesh. The inspection was conducted from 24th October 2022 to 28th October 2022. We have been issued a Form 483 with one observation. The observation is procedural in nature. The Company will address the observation within stipulated timelines.
28-10-2022

Buy Laurus Labs; target of Rs 600: Sharekhan

Sharekhan is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 600 in its research report dated October 25, 2022.
27-10-2022
Bigul

Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Transcript of Q2 FY '23 Earnings Conference Call hosted on October 21, 2022
25-10-2022
Next Page
Close

Let's Open Free Demat Account